Prevalence and Antibiotic Susceptibility Profile of Isolated Blse-Producing Klebsiella SPP in Urinary Tract Infections at FANN National University Hospital (Dakar/Senegal).

Niokhor Ngobe Sene; Aissatou Ahmet Niang; Madiagne Der; Fatoumata Diallo; Aissatou Gaye; Youssoupha Fall; Sény Ndiaye; Mouhamadou Lamine Dia

doi:10.52589/AJBMR-ZHACEWRG

Loading...

Prevalence and Antibiotic Susceptibility Profile of Isolated Blse-Producing Klebsiella SPP in Urinary Tract Infections at FANN National University Hospital (Dakar/Senegal).

;
;
;
;
;
;
;

Publication Date: 2024-07-12

DOI: 10.52589/AJBMR-ZHACEWRG

Volume/Issue: Volume 7, Issue 3 (2024)

Page No: 1 - 8

Journal: African Journal of Biology and Medical Research

Share Link

𝕏

Cite this

Citation unavailable for this article.

Abstract:

This is a retrospective study covering the period 2022-2023 on urine samples received at the bacteriology-virology laboratory of the CHNU of FANN. The aim was to determine the prevalence and sensitivity profile of ESBL-producing strains of Klebsiella spp to other antibiotic molecules. A total of 549 urine samples were positive for a bacterium, of which 113 (20.58%) were attributable to Klebsiella spp., with a predominance of Klebsiella pneumoniae n=90 (79.65%). 59.26% were producers of extended-spectrum betalactamase (ESBL), of which 56.25% (n=27/48) were of hospital origin. Good sensitivity was noted to imipenem (78.40%) and amikacin (70.59%).

Keywords:ESBLKlebsiella sppUrinary tractAntibiotics.

Downloads: 405

Copyrights

Authors retain copyright in their articles and have unrestricted rights to reuse, republish, archive, share, and distribute their work after publication.
All articles are published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, including for commercial purposes, provided appropriate credit is given to the original author(s) and source.

Loading…

Copyrights

Authors retain copyright in their articles and have unrestricted rights to reuse, republish, archive, share, and distribute their work after publication.
All articles are published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, including for commercial purposes, provided appropriate credit is given to the original author(s) and source.